Extracellular vesicles as biomarker and therapeutic targets for neurological disorders DOI

Ufaq Razi,

Faizan Ahmad, Anik Karan

и другие.

Elsevier eBooks, Год журнала: 2025, Номер unknown, С. 105 - 137

Опубликована: Янв. 1, 2025

Язык: Английский

The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis DOI Open Access
Simran Rastogi, Vaibhav Sharma, Prahalad Singh Bharti

и другие.

International Journal of Molecular Sciences, Год журнала: 2021, Номер 22(1), С. 440 - 440

Опубликована: Янв. 4, 2021

Neurodegenerative diseases (ND) remains to be one of the biggest burdens on healthcare systems and serves as a leading cause disability death. Alzheimer’s disease (AD) is among most common such disorders, followed by Parkinson’s (PD). The basic molecular details initiation pathology are still under research. Only recently, role exosomes has been linked progression these neurodegenerative diseases. Exosomes small bilipid layer enclosed extracellular vesicles, which were once considered cellular waste functionless. These nano-vesicles 30–150 nm in diameter carry specific proteins, lipids, functional mRNAs, high amounts non-coding RNAs (miRNAs, lncRNAs, circRNAs). As content known vary per their originating recipient cells, vesicles can utilized diagnostic biomarker for early detection. Here we review exosomes, biogenesis, composition, We have also provided characterization through an array available techniques. Their updated discussed. Finally, shed light novel field salivary potential candidate diagnosis compared biomarkers with other blood/cerebrospinal fluid (CSF) based within neurological ailments.

Язык: Английский

Процитировано

128

The Emerging Role of Neural Cell-Derived Exosomes in Intercellular Communication in Health and Neurodegenerative Diseases DOI Creative Commons

Luyao Huo,

Xinzhe Du,

Xinrong Li

и другие.

Frontiers in Neuroscience, Год журнала: 2021, Номер 15

Опубликована: Авг. 31, 2021

Intercellular communication in the central nervous system (CNS) is essential for brain growth, development, and homeostasis maintenance and, when dysfunctional, involved occurrence development of neurodegenerative diseases. Increasing evidence indicates that extracellular vesicles, especially exosomes, are critical mediators intercellular signal transduction. Under physiological pathological conditions, neural cells secret exosomes with influence many factors. These can carry specific proteins, lipids, nucleic acids, other bioactive substances to recipient regulate their function. Depending on CNS environment, as well origin or status parental cells, mediate a variety different effects, including synaptic plasticity, nutritional metabolic support, nerve regeneration, inflammatory response, anti-stress effect, cellular waste disposal, propagation toxic components, playing an important role health This review will discuss possible roles both physiologic conditions.

Язык: Английский

Процитировано

84

Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis DOI Creative Commons
Kim A. Staats, David Borchelt, Malú G. Tansey

и другие.

Molecular Neurodegeneration, Год журнала: 2022, Номер 17(1)

Опубликована: Янв. 24, 2022

Abstract Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in which many processes are detected including (neuro)inflammation. Many drugs have been tested for ALS clinical trials but most failed to reach their primary endpoints. The development and inclusion of different types biomarkers diagnosis can assist determining target engagement drug, distinguishing between other diseases, predicting progression rate, drug responsiveness, or an adverse event. Ideally, among characteristics, biomarker correlates highly with process the central nervous system conveniently obtained peripheral tissue. Here, we describe state inflammation by focusing on peripherally detectable cellular responses from blood cells, provide new (combinatorial) directions exploration that now feasible due technological advancements.

Язык: Английский

Процитировано

51

MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases DOI Open Access
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele

и другие.

International Journal of Molecular Sciences, Год журнала: 2022, Номер 23(9), С. 4718 - 4718

Опубликована: Апрель 25, 2022

MicroRNAs (miRNAs) are essential post-transcriptional gene regulators involved in various neuronal and non-neuronal cell functions play a key role pathological conditions. Numerous studies have demonstrated that miRNAs dysregulated major neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s multiple sclerosis, amyotrophic lateral or Huntington’s disease. Hence, the present work, we constructed comprehensive overview of individual microRNA alterations models above diseases. We also provided evidence promising biomarkers for prognostic diagnostic approaches. In addition, summarized data from literature about miRNA-based therapeutic applications via inhibiting promoting miRNA expression. finally identified overlapping signature across including miR-128, miR-140-5p, miR-206, miR-326, miR-155, associated with etiological cellular mechanisms. However, it remains to be established whether what extent therapies could safely exploited future effective symptomatic disease-modifying approaches different human disorders.

Язык: Английский

Процитировано

51

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases DOI Creative Commons
Xiaohuan Xia, Yi Wang, Jialin Zheng

и другие.

Translational Neurodegeneration, Год журнала: 2022, Номер 11(1)

Опубликована: Дек. 12, 2022

Abstract Extracellular vesicles (EVs) are small bilipid layer-enclosed that can be secreted by all tested types of brain cells. Being a key intercellular communicator, EVs have emerged as contributor to the pathogenesis various neurodegenerative diseases (NDs) including Alzheimer’s disease, Parkinson’s amyotrophic lateral sclerosis, and Huntington’s disease through delivery bioactive cargos within central nervous system (CNS). Importantly, CNS cell-derived purified via immunoprecipitation, EV with altered levels been identified potential biomarkers for diagnosis prognosis NDs. Given essential impact on NDs, pathological considered therapeutic targets effects utilized agents or drug platforms treatment In this review, we focus recent research progress roles released from cells in summarize findings identify CNS-derived diagnose comprehensively discuss promising targets, agents, systems treating together current concerns challenges basic clinical applications regarding

Язык: Английский

Процитировано

49

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases DOI Open Access
Giulia Gentile, Giovanna Morello, Valentina La Cognata

и другие.

Journal of Personalized Medicine, Год журнала: 2022, Номер 12(5), С. 770 - 770

Опубликована: Май 10, 2022

Alzheimer’s disease (AD), Parkinson’s (PD), and Amyotrophic Lateral Sclerosis (ALS) are representative neurodegenerative diseases (NDs) characterized by degeneration of selective neurons, as well the lack effective biomarkers therapeutic treatments. In last decade, microRNAs (miRNAs) have gained considerable interest in diagnostics therapy NDs, owing to their aberrant expression ability target multiple molecules pathways. Here, we provide an overview dysregulated miRNAs fluids (blood or cerebrospinal fluid) nervous tissue AD, PD, ALS patients. By emphasizing those that commonly these highlight potential role therapeutical targets describe use antisense oligonucleotides miRNA therapies.

Язык: Английский

Процитировано

46

Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis DOI Open Access
Maruša Barbo, Metka Ravnik‐Glavač

Genes, Год журнала: 2023, Номер 14(2), С. 325 - 325

Опубликована: Янв. 27, 2023

Amyotrophic lateral sclerosis (ALS) is described as a fatal and rapidly progressive neurodegenerative disorder caused by the degeneration of upper motor neurons in primary cortex lower brainstem spinal cord. Due to ALS’s slowly characteristic, which often accompanied other neurological comorbidities, its diagnosis remains challenging. Perturbations vesicle-mediated transport autophagy well cell-autonomous disease initiation glutamatergic have been revealed ALS. The use extracellular vesicles (EVs) may be key accessing pathologically relevant tissues for ALS, EVs can cross blood–brain barrier isolated from blood. number content provide indications pathogenesis, stage, prognosis. In this review, we collected recent study aiming at identification biomarker ALS with respect size, quantity, biological fluids patients compared controls.

Язык: Английский

Процитировано

22

Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers? DOI Creative Commons
Rocío del Carmen Bravo-Miana, Jone Karmele Arizaga-Echebarria, David Otaegui

и другие.

Translational Neurodegeneration, Год журнала: 2024, Номер 13(1)

Опубликована: Июнь 19, 2024

Abstract The central nervous system (CNS) is integrated by glial and neuronal cells, both release extracellular vesicles (EVs) that participate in CNS homeostasis. EVs could be one of the best candidates to operate as nanosized biological platforms for analysing multidimensional bioactive cargos, which are protected during systemic circulation EVs. Having a window into molecular level processes happening open new avenue research. This raises particular point interest: can CNS-derived blood serve circulating biomarkers reflect pathological status neurological diseases? L1 cell adhesion molecule (L1CAM) widely reported biomarker identify peripheral blood. However, it has been demonstrated L1CAM also expressed outside CNS. Given principal data related neurodegenerative diseases, such multiple sclerosis, amyotrophic lateral Parkinson’s disease Alzheimer’s were obtained using L1CAM-positive EVs, efforts overcome present challenges its specificity required. In this sense, other surface glutamate aspartate transporter (GLAST) myelin oligodendrocyte glycoprotein (MOG), among others, have started used. Establishing panel EV analyse increase sensitivity necessary these types studies. review covers main evidence cerebrospinal fluid samples patients with focusing on technical possibilities their isolation. emerging mirror brain physiopathology, reflecting localized changes. Therefore, when hindrances research clinical applications overcome, novel disease-specific panels would discovered facilitate transformation from traditional medicine personalized medicine.

Язык: Английский

Процитировано

11

Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review DOI Creative Commons
Shahram Darabi,

Armin Ariaei,

Auob Rustamzadeh

и другие.

Diagnostic Pathology, Год журнала: 2024, Номер 19(1)

Опубликована: Март 1, 2024

Abstract Background Amyotrophic lateral sclerosis (ALS) is a progressive and fatal motor neuron disease. Due to the limited knowledge about potential biomarkers that help in early diagnosis monitoring disease progression, today’s diagnoses are based on ruling out other diseases, neurography, electromyography examination, which takes time-consuming procedure. Methods PubMed, ScienceDirect, Web of Science were explored extract articles published from January 2015 June 2023. In searching strategy following keywords included; amyotrophic sclerosis, biomarkers, cerebrospinal fluid, serum, plama. Results A total number 6 studies describing fluid-based exosomal included this study. Aggregated proteins including SOD1, TDP-43, pTDP-43, FUS could be detected microvesicles (MVs). Moreover, TDP-43 NFL extracted plasma exosomes used as prognostic biomarkers. Also, downregulated miR-27a-3p through exoEasy Maxi exoQuick Kit measured diagnostic biomarker. Eventually, upregulated level CORO1A monitor progression. Conclusion Based results, each biomarker alone insufficient evaluate ALS. CNS-derived contain multiple ALS-related (SOD1, FUS, miRNAs) detectable fluid blood proper alternation. Exosome detecting kits listed exoEasy, ExoQuick, Exo-spin, ME kit, ExoQuick Plus, Exo-Flow, helpful reach purpose.

Язык: Английский

Процитировано

9

Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers DOI Creative Commons
Delia Gagliardi, Nereo Bresolin, Giacomo P. Comi

и другие.

Cellular and Molecular Life Sciences, Год журнала: 2020, Номер 78(2), С. 561 - 572

Опубликована: Авг. 16, 2020

Abstract Extracellular vesicles (EVs) are small reservoirs of different molecules and important mediators cell-to-cell communication. As putative vehicles misfolded protein propagation between cells, they have drawn substantial attention in the field amyotrophic lateral sclerosis (ALS) other neurodegenerative disorders. Moreover, exosome-mediated non-coding RNA delivery may play a crucial role ALS, given relevance homeostasis disease pathogenesis. Since EVs can enter systemic circulation easily detectable patients’ biological fluids, generated broad interest both as diagnostic prognostic biomarkers valuable tools understanding Here, after brief introduction on biogenesis functions EVs, we aim to investigate their disorders, especially ALS. Specifically, focus main findings supporting EV-mediated transmission ALS vitro vivo models. Then, provide an overview clinical applications summarizing most relevant studies able detect blood cerebrospinal fluid (CSF) patients, underlying potential use aiding diagnosis prognosis. Finally, explore therapeutic either targets or proteins, nucleic acids molecular drugs.

Язык: Английский

Процитировано

57